Closing arguments are expected in the West Virginia trial next week [7/26/21 – 7/30/21]. Local West Virginia communities had opted out of the proposed nationwide deal to pursue one on their own. States will have 30 days to decide whether to join the global accord then more time to try to convince their cities and…
If Bryan Roth… has his way, psychedelics could change forever… “There are plenty of psychedelics out there,” he added. “We don’t need any more psychedelics.” … “They want to transform the treatment of depression, with a pill, basically,” Roth said of DARPA… brought together a “dream team” of scientists to work on the project, including…
…the company is also developing novel molecules based on other psychedelic compounds. The company has filed 12 provisional patent applications for novel psychedelic molecules… Thomas Laughren, a medical doctor who served as the director of the U.S. Food and Drug Administration’s division of psychiatry products for nearly three decades… …left his post at the FDA…
While ibogaine has demonstrated anti-anxiety and anti-depression effects and is used in some drug and alcohol rehab clinics around the world… Ibogaine’s successes – as well as the successes of psilocybin and ketamine — suggest that psychedelics may one day be recognized as powerful medicines… in his lab at University of California Davis Olson wondered whether the psychedelic effects of drugs…
…supports a proposed U.S. legislation to legalize cannabis at the federal level… Amazon was hit with a proposed class action suit, which claimed that the company was violating a New York City law by testing applicants for jobs at local facilities for marijuana… the company does not allow marijuana sales on its platform. Original Article…
It’s not clear if the Department of Justice will issue a new cannabis prosecution guidance memo under… [new head of DEA, Anne Milgram, former Attorney General of New Jersey]… she has publicly stated her opposition to even modest reforms such as state-level efforts to simply decriminalize marijuana [in the past]… William Barr, maintained that Congress…
Francis Collins, director of the National Institutes of Health (NIH) expressed positive remarks about the therapeutic potential of psychedelics such as psilocybin and MDMA. “I think as we’ve learned more about how the brain works we began to realize that these are potential tools for research purposes and might be clinically beneficial,” Collins said. The…
[These removed California psychedelic decriminalization SB 519 sections] would have had a major impact on getting people out of jail for the possession of drugs that look to be on the verge of decriminalization. We’ve seen a lot of family reunification stories in cannabis over the past few years – it will be nice to…
Appearing before a congressional panel… December [2020], members of the Sackler family said they had done nothing wrong. “The family and the board acted legally and ethically,” testified David Sackler, who served on Purdue Pharma’s board for six years. This development brings members of the Sackler family, some of whom own Purdue Pharma and served on…
Canadian company… when Wake applied, the company says it was the first to submit the request to the International Narcotics Control Board (INCB) and the UN office on Drugs and Crime (UNODC)… prior to Wake’s application, psilocybin was not included on the INCB’s [International Narcotics Control Board (INCB)] list until the company requested that it…
Recent Comments